Haemonetics (HAE) Short-Term Debt issuances (2016 - 2020)
Haemonetics has reported Short-Term Debt issuances over the past 12 years, most recently at -$150.0 million for Q4 2020.
- Quarterly results put Short-Term Debt issuances at -$150.0 million for Q4 2020, down 3100.0% from a year ago — trailing twelve months through Oct 2021 was -$150.0 million (down 236.36% YoY), and the annual figure for FY2021 was -$60.0 million, down 233.33%.
- Short-Term Debt issuances for Q4 2020 was -$150.0 million at Haemonetics, down from -$60.0 million in the prior quarter.
- Over the last five years, Short-Term Debt issuances for HAE hit a ceiling of $150.0 million in Q2 2020 and a floor of -$150.0 million in Q4 2020.
- Median Short-Term Debt issuances over the past 5 years was $145000.0 (2016), compared with a mean of -$3.2 million.
- Biggest five-year swings in Short-Term Debt issuances: crashed 18300.46% in 2016 and later soared 16204.35% in 2019.
- Haemonetics' Short-Term Debt issuances stood at -$39.9 million in 2016, then surged by 100.41% to $162000.0 in 2017, then plummeted by 43.21% to $92000.0 in 2018, then surged by 5334.78% to $5.0 million in 2019, then plummeted by 3100.0% to -$150.0 million in 2020.
- The last three reported values for Short-Term Debt issuances were -$150.0 million (Q4 2020), -$60.0 million (Q3 2020), and $150.0 million (Q2 2020) per Business Quant data.